Bortezomib/dexamethasone

Bortezomib/Dexamethasone

Bortezomib/Dexamethasone (pronunciation: bor-tez-oh-mib/dex-a-meth-a-sone) is a combination of two drugs, Bortezomib and Dexamethasone, used in the treatment of multiple myeloma, a type of blood cancer.

Etymology

The term "Bortezomib" is derived from its chemical name, [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid. "Dexamethasone" is derived from its chemical name, 9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione.

Bortezomib

Bortezomib is a type of chemotherapy drug known as a proteasome inhibitor. It works by blocking the action of proteasomes, which are complexes inside cells that break down proteins. By blocking this action, bortezomib can cause cancer cells to die.

Dexamethasone

Dexamethasone is a type of corticosteroid medication. It is used in combination with other medications, including bortezomib, to treat multiple myeloma. Dexamethasone works by decreasing inflammation and modifying the body's immune response.

Related Terms

• Chemotherapy
• Proteasome inhibitor
• Corticosteroid
• Multiple Myeloma
• Inflammation
• Immune response

See Also

• Chemotherapy
• Corticosteroids
• Multiple Myeloma
• Inflammation
• Immune response

External links

• Medical encyclopedia article on Bortezomib/dexamethasone
• Wikipedia's article - Bortezomib/dexamethasone

This WikiMD dictionary article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski